Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

American Cannabis Partners Poised for Expansion, Seeks Growth Opportunities as Reliable Business Partner

ACP’s strategy is based on leveraging opportunities in real estate and licensing in states that have recently passed legalization legislation Focused on complementary business segments — real estate, acquisition and development of proprietary assets, and ongoing cultivation operations, ACP appears poised for expansion Company seeks partnerships with companies with aligned personal, ethical, and business sensibilities […]

InnerScope Hearing Technologies Inc. (INND) Goes All-in to Disrupt Traditional Hearing Health Care Amid Announced Liberalization of US Hearing Aids Market

InnerScope Hearing Technologies prepares to launch first in a series of National Hearing Loss Blitz Media Campaigns to raise hearing problems awareness and showcase company’s unique hearing aid solutions as US government pushes for more accessible hearing aids market Campaign expected to drive sales of its revolutionary Direct-to-Consumer, rechargeable app-controlled hearing aids and other services […]

Perpetual Industries Inc. (PRPI) Acquisition Activity Strengthens Position in Billion-Dollar Classic Car Sector — AutoGrafic Acquisition Brings Much-Needed New Technology and Innovation to Collector Car Enthusiasts and the Industry at Large

Bloomberg article reports that sales of classic cars have remained “positively stable” during global pandemic Two key acquisitions help firmly establish PRPI’s position in multibillion-dollar classic car market CEO notes that PRPI’s acquisition of Worldwide Auctioneers will lead to company’s greater growth While COVID-19 may have dampened the new-car market, a recent Bloomberg article noted […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Steadily Achieving Its Operational and Business Plan Objectives

Lexaria just completed dosing for its second human clinical study, HYPER-H21-2 The study sought to understand the human response to Lexaria’s DehydraTECH 2.0-enabled CBD The company also announced that its DehydraTECH-enabled consumer products are available for purchase in over 7,000 stores across the United States Lexaria also expanded its intellectual property portfolio with the allowance […]

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Expands Testing Capabilities by Signing First Amendment to Abbott Distribution Agreement; Partners with Ellerca Health Inc to Support Patients’ Needs

Avricore Health signed the first amendment to its supplier distribution agreement between subsidiary HealthTab and Abbott The amendment adds to the agreement Abbott’s ID Now(TM) molecular testing device, which will bring in onsite testing and reporting capabilities for SARS-CoV-2 (Covid-19), RSV, Influenza A & B, and Strep Avricore also announced its partnership with Ellerca Health, […]

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Launches Second Stage of Manufacturing of Ibogaine for Clinical Research

The company has filed patent applications for two routes of chemical synthesis of ibogaine – offering potential advantages of improved isomeric purity, chiral purity, and easily isolated intermediate compounds Preliminary data indicates that the drug shows promise as a treatment for neuropathic pain and migraines, as well as the treatment of addiction The company is […]

 

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Driving Innovation in Photodynamic Therapy Potential in Oncology, Dermatology

February 10, 2026

From lab research to clinical application, photodynamic therapy (“PDT”) is emerging as a powerful treatment approach that uses light and chemistry to selectively target diseased tissue. As this modality gains attention for its precision and safety profile, Soligenix (NASDAQ: SNGX) is developing light-activated therapies designed to treat cutaneous T-cell lymphoma (“CTCL”) and other inflammatory skin […]

Rotate your device 90° to view site.